Whitehawk Therapeutics (WHWK) Other Non Operating Income (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 8 years of Other Non Operating Income data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 98.49% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 96.41% decrease from a year earlier, with the FY2025 full-year figure at $93.8 million, up 2345200.0% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $1.3 million, down from $1.6 million in the prior quarter.
• Over the last five years, Other Non Operating Income for WHWK reached as high as $88.2 million in Q1 2025 and fell as low as -$3.1 million in Q4 2024.
• Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of $1.0 million in 2024.
• Across the five-year window, Other Non Operating Income plunged 150.15% in 2024 and jumped 8823500.0% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $1.5 million in 2022, then surged by 298.13% to $6.2 million in 2023, then plunged by 150.15% to -$3.1 million in 2024, then surged by 152.86% to $1.6 million in 2025, then declined by 18.83% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $1.3 million in Q1 2026, $1.6 million in Q4 2025, and $158000.0 in Q2 2025.